Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Mutualfunds logo

EMHSX Eaton Vance Worldwide Health Sci B

  • Fund
  • EMHSX
  • Price as of: May 25, 2018
  • $10.71
  • + $0.01
  • + 0.09%
  • Category
  • Health & Biotech Equities

EMHSX - Profile

Vitals

  • YTD Return 1.9%
  • 3 Yr Annualized Return -0.6%
  • 5 Yr Annualized Return 9.9%
  • Net Assets $992 M
  • Holdings in Top 10 38.6%

52 WEEK LOW AND HIGH

$10.71
$10.15
$11.46

Expenses

OPERATING RELATED FEES

  • Expense Ratio 2.10%

SALES FEES

  • Front Load N/A
  • Deferred Load 5.00%

BROKERAGE FEES

  • Turnover 36.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

Closed to new investors as of 2012-01-02

STANDARD (TAXABLE)

$1,000

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 1.9%
  • 3 Yr Annualized Total Return -1.6%
  • 5 Yr Annualized Total Return 9.7%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.79%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Eaton Vance Worldwide Health Sciences Fund
  • Fund Family Name Eaton Vance
  • Inception Date Sep 23, 1996
  • Shares Outstanding 346826
  • Share Class B
  • Currency USD
  • Domiciled Country United States
  • Manager Jason A. Kritzer

EMHSX - Performance

Return Ranking - Trailing

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 1.9% -14.9% 22.3% 78.57% 4
1 Yr 3.2% -14.8% 39.2% 83.78% 5
3 Yr -0.6% * -7.5% 17.2% 86.11% 5
5 Yr 9.9% * 6.5% 21.2% 89.72% 5
10 Yr 10.2% * 6.1% 18.4% 83.50% 5

* Annualized


Return Ranking - Calendar

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
2017 12.3% -19.5% 43.9% 63.64% 4
2016 -24.9% -29.8% 14.5% 94.55% 5
2015 -1.9% -20.4% 33.7% 46.36% 3
2014 8.8% -5.8% 48.1% 71.82% 4
2013 28.2% -3.1% 65.2% 74.31% 4

Total Return Ranking - Trailing

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 1.9% -14.9% 22.3% 79.28% 4
1 Yr -1.8% -18.3% 39.2% 91.82% 5
3 Yr -1.6% * -14.2% 16.4% 88.89% 5
5 Yr 9.7% * 5.8% 21.2% 86.92% 5
10 Yr 10.2% * 6.1% 18.4% 80.58% 4

* Annualized


Total Return Ranking - Calendar

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
2017 12.3% -19.5% 43.9% 64.22% 4
2016 -24.9% -25.1% 39.1% 98.17% 5
2015 8.1% -16.6% 100.0% 47.71% 3
2014 35.9% -5.8% 79.8% 45.87% 3
2013 84.9% 0.0% 398.7% 34.26% 2

NAV & Total Return History

EMHSX - Holdings

Filings data as of: Mar 31, 2018

Concentration Analysis

EMHSX Category Low Category High EMHSX % Rank Quintile
Net Assets 992 M 16.9 M 44.7 B 19.64% 3
Number of Holdings 59 31 363 25.89% 5
Net Assets in Top 10 382 M 10 M 18.4 B 21.43% 3
Weighting of Top 10 38.6% 21.3% 74.7% 20.54% 3

Top 10 Holdings

  1. Pfizer Inc 4.07%
  2. UnitedHealth Group Inc 6.08%
  3. Johnson & Johnson 6.44%
  4. Bayer AG 3.44%
  5. AbbVie Inc 3.68%
  6. Gilead Sciences Inc 2.88%
  7. Bristol-Myers Squibb Company 3.25%
  8. Intuitive Surgical Inc 3.09%
  9. Danaher Corp 2.88%
  10. Thermo Fisher Scientific Inc 2.82%

Asset Allocation

Weighting Category Low Category High EMHSX % Rank Quintile
Stocks
99.28% 92.18% 99.73% 6.25% 1
Other
0.67% -3.17% 5.15% 5.36% 1
Cash
0.05% 0.00% 7.67% 33.04% 5
Preferred Stocks
0.00% 0.00% 2.21% 10.71% 5
Convertible Bonds
0.00% 0.00% 0.47% 3.57% 5
Bonds
0.00% 0.00% 4.69% 3.57% 5

Stock Sector Breakdown

Weighting Category Low Category High EMHSX % Rank Quintile
Healthcare
98.19% 9.78% 99.72% 2.68% 1
Technology
1.09% 0.00% 69.25% 16.96% 3
Utilities
0.00% 0.00% 0.48% 1.79% 5
Real Estate
0.00% 0.00% 1.07% 2.68% 5
Industrials
0.00% 0.00% 8.36% 8.93% 5
Financial Services
0.00% 0.00% 6.46% 6.25% 5
Energy
0.00% 0.00% 0.11% 1.79% 5
Communication Services
0.00% 0.00% 0.00% 0.89% 5
Consumer Defense
0.00% 0.00% 1.31% 10.71% 5
Consumer Cyclical
0.00% 0.00% 7.68% 8.04% 5
Basic Materials
0.00% 0.00% 0.58% 2.68% 5

Stock Geographic Breakdown

Weighting Category Low Category High EMHSX % Rank Quintile
US
78.35% 63.02% 99.66% 31.25% 4
Non US
20.93% 0.00% 36.70% 5.36% 1

EMHSX - Expenses

Operational Fees

EMHSX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 2.10% 0.10% 4.31% 12.50% 5
Management Fee 0.81% 0.09% 1.25% 7.14% 4
12b-1 Fee 1.00% 0.00% 1.00% 1.27% 5
Administrative Fee 0.15% 0.01% 0.40% 6.15% 4

Sales Fees

EMHSX Fees (% of AUM) Category Low Category High EMHSX Rank Quintile
Front Load N/A 2.50% 5.75% N/A N/A
Deferred Load 5.00% 1.00% 5.00% 3.03% 5

Trading Fees

EMHSX Fees (% of AUM) Category Low Category High EMHSX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

EMHSX Fees (% of AUM) Category Low Category High EMHSX Rank Quintile
Turnover 36.00% 0.00% 699.00% 18.75% 3

EMHSX - Distributions

Dividend Yield Analysis

EMHSX Category Low Category High EMHSX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

EMHSX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

EMHSX Category Low Category High EMHSX % Rank Quintile
Net Income Ratio -0.79% -2.22% 1.46% 53.57% 4

Capital Gain Distribution Analysis

EMHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

EMHSX - Managers

Jason A. Kritzer

Manager

Start Date

Jul 01, 2016

Tenure

1.83

Tenure Rank

23.8%

Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.


Samantha Pandolfi

Manager

Start Date

Jul 01, 2016

Tenure

1.83

Tenure Rank

23.8%

Ms. Pandolfi is a Vice President of EVAIL. Prior to joining EVAIL, Ms. Pandolfi held similar positions at EVMI. Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure (2000-2015).


Tenure Analysis

Category Low

0.0

Category High

20.6

Category Average

9.31

Category Mode

3.3